Cargando…
Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
BACKGROUND: Intrahepatic cholangiocarcinoma (iCCA) is a highly lethal malignancy of the biliary tract. Analysis of somatic mutational profiling can reveal new prognostic markers and actionable treatment targets. In this study, we explored the utility of genomic mutation signature and tumor mutation...
Autores principales: | Zhang, Rui, Li, Qi, Fu, Jialu, Jin, Zhechuan, Su, Jingbo, Zhang, Jian, Chen, Chen, Geng, Zhimin, Zhang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860034/ https://www.ncbi.nlm.nih.gov/pubmed/33535978 http://dx.doi.org/10.1186/s12885-021-07788-7 |
Ejemplares similares
-
High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022) -
TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022) -
Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study
por: Li, Qi, et al.
Publicado: (2022) -
An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
por: He, Chaobin, et al.
Publicado: (2021) -
IDH Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
por: Xiang, Xiao, et al.
Publicado: (2021)